Study to Assess the Antiviral Activity and Safety Endpoints for the Treatment of Besifovir 150mg Compared to Tenofovir 300mg in Chronic Hepatitis B Patients Who Have Resistance to Nucleoside Analogues
PHASE3
To prove that a study drug is noninferior to a control drug with a proporti...
Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection
PHASE2
This study is a phase II multicenter, randomized, double-blind, placebo con...
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
PHASE1
This sponsor-open, investigator- and participant-blinded, multi-center stud...
Status
Completed
Location
Gastroenterology department, Second clinic of internal diseases
Study to Evaluate the Safety, Tolerability, and Antiviral Activity of Selgantolimod (Formerly GS-9688) in Viremic Adult Participants With Chronic Hepatitis B (CHB) Who Are Not Currently on Treatment
PHASE2
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Completed
Location
University of Calgary Liver Unit - Heritage Medical Research Clinic
A Study of Safety and Efficacy of ATI-2173 in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection and in Subjects With Hepatitis D Virus Coinfection
PHASE2
This is a randomized, double-blinded, placebo-controlled, multi center, dos...
Status
Terminated
Location
Republican Clinical Hospital "Timofei Mosneaga" Arensia EM Unit
This is a Phase 1 Study in Which Healthy Volunteers and Participants with Chronic HBV Infection Will Receive HT-101 or Placebo and Will Be Assessed for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity
PHASE1
Phase 1 Study of HT-101 in Healthy Subjects and Patients With Chronic Hepat...